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Amniotic fluid C-reactive protein as 
a predictor of infection in caesarean 
section: a feasibility study
Zbigniew Marchocki1, Angela Vinturache2, Kevin Collins3, Paddy O’ Reilly3 & Keelin O’Donoghue1,4
This study evaluated the feasibility of maternal C-reactive protein (CRP) in amniotic fluid (AF) as a 
predictor of post-partum infection in women who undergo emergency or elective caesarean section 
(CS). AF bacterial culture and levels of hs-CRP in maternal serum and AF were evaluated in Day 0 and 
three days thereafter (Day 3) in 79 women undergoing CS. Univariate analyses assessed the clinical and 
demographic characteristics, whereas the ROC curves assessed the feasibility of hs-CRP as marker of 
inflammation in women who undergo CS. There was no difference in AF, Day 0, and Day 3 serum hs-
CRP levels between women with sterile compared to those with bacterial growth in AF. Among women 
with positive AF cultures, AF and Day 0 serum hs-CRP levels were higher in women who underwent 
emergency compared to those who had elective CS (p = 0.04, and p = 0.02 respectively). hs-CRP in Day 
0 and Day 3 serum but not in AF has a fair predictor value of infection in emergency CS only (AUC 0.767; 
95% CI 0.606–0.928, and AUC 0.791; 95% CI 0.645–0.036, respectively). We conclude that AF hs-CRP is 
not feasible in assessing the risk of post-cesarean inflammation or infection.
The proportion of births delivered by caesarean section (CS) has increased worldwide significantly over the past 
three decades, currently approximately 18.6% of pregnancies being delivered by CS1. There is considerable vari-
ation among countries and regions, particularly in rates of emergency CS, the reported rates of CS ranging from 
6.0% to 27.2% in the least and most developed regions, respectively2. For instance, CS rates vary from 1% in 
Nigeria to 46% in Brazil3. High CS rates have been reported in the UK and Australia, where 26.5% and 32.3% of 
births are by CS, respectively4. In the USA, was reported a 41% increase in incidence in a 13-year period5, while 
in Ireland the CS rate increased from 20.5% in 1999 to 25.6% in 20166,7. As CS has become safer and electively 
scheduled, functional and cosmetic aspects, as well as risks of hospital-acquired infection have gained increased 
importance8.
Women undergoing CS have a 5 to 20-fold greater risk for infectious morbidity compared to vaginal delivery9. 
It is estimated that postoperative rates of infection after CS range between 1.2 and 5.0% for women during their 
inpatient stay8,10–12. It is likely that the overall rates of infection may be even higher than these estimates consid-
ering the typical short postoperative hospital stay of 2 to 4 days after a CS. Wound infection, urinary tract infec-
tion, endometritis and fever occur in 8% of women after CS13. Most frequent infectious complications following 
cesarean birth include fever (febrile morbidity), skin and soft tissue infection (wound infection), endometritis 
(inflammation of the lining of the uterus), and urinary tract infection which occur in 8% of women. Occasionally, 
serious infectious complications may occur including pelvic abscess, bacteremia, septic shock, necrotizing fasci-
itis, and septic pelvic vein thrombophlebitis which can lead to maternal mortality14,15. It is estimated that around 
80% of complications occur after hospital discharge. With the increase in CS rates worldwide, it is anticipated that 
related infections will become an increasing health and economic burden1,13, through their associated morbidity, 
increased hospital stay or re-admission after delivery13.
Factors associated with an increased risk of infection in women after CS include emergency procedures, dura-
tion of labor, ruptured membranes, vaginal examination in labor, internal fetal monitoring, obesity, blood loss 
and operative technique1,13. The most important source is the genital tract, especially if membranes are ruptured 
before delivery. Even during normal delivery, 70–90% of amniotic fluid becomes colonized with microbes16. 
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Given the importance of these infections, and the absence of effective surveillance following CS, it is imperative 
to develop methods able to predict the risk of postoperative infection after CS that could be implemented at 
admission for labour and delivery.
C-reactive protein (CRP), an acute phase reactant protein, is a biological marker of value in detecting infec-
tious complications. CRP is a member of pentraxin family of proteins, that is secreted into the circulation from 
the liver as a reaction to the onset of inflammation and/or acute tissue injury. CRP is also produced by cells in the 
vascular wall such as endothelial cells, smooth muscle cells, and also by the adipose tissue. CRP has been exten-
sively examined in the context of preterm prelabour rupture of membranes premature labor and delivery17–19. 
Maternal serum CRP was assumed to be a clinical indicator for women with preterm labour or preterm rupture 
of membranes related to the possible preceding subclinical maternal infection18,20. Maternal CRP concentration 
level was shown to be significantly higher before, during, and after the labour in patients with Fetal Inflammatory 
Response Syndrome (FIRS)21. However, there have been no recent studies performed on the use of amniotic fluid 
(AF) markers as predictors of postoperative infectious morbidity post CS in term pregnancies.
Whereas standard CRP tests traditionally measure CRP down to concentrations of 3–5 mg/L, high sensitivity 
CRP (hs-CRP) also called ultra-sensitive CRP, measures down to levels around 0.3 mg/L. This improved sensi-
tivity allows hs-CRP to be used to detect low-grade inflammation (<2.0 mg/L). Since higher values (>10 mg/l) 
confirm clinically evident infection, lower values might suggest chronic inflammatory processes, subclinical 
infection, or early stage infection. Therefore, elevated hs-CRP in AF could suggest an evolving infectious process 
and might have a role in predicting the risk of postoperative infectious morbidity.
Isolating bacterial organisms from the AF would provide a final diagnosis of infection, being considered the 
gold standard in diagnosis of infection. However, this is time-consuming and often is negative, since up to 99% 
or more of microbial species visualized by microscopy are uncultivable. Thus, measurement of AF hs-CRP might 
have a role in diagnosing subclinical or an early infectious process that has already started in utero, which might 
not manifest as an active infection until later in the post-partum period.
This study was designed to evaluate the feasibility of hs-CRP measurement in AF at the time of CS in pre-
dicting inflammation in early postpartum period. In addition, by comparison, we assessed whether hs-CRP lev-
els in serum at the time of CS and in the immediate postpartum period is correlated with postnatal infectious 
complications.
Methods
Ethical approval. The study was approved by the Clinical Research Ethics Committee of the Cork University 
Hospital (ECM 4: 02/08/2011). Informed written consent was obtained from the study participants at the time of 
recruitment, for use of clinical information and biological sample collection. All experiments were performed in 
accordance with the relevant guidelines and regulations.
Study population. This was a prospective observational cohort study of 79 pregnant women undergoing 
CS at Cork University Hospital, a large teaching hospital, with around 8,500 deliveries per year in Cork, Ireland. 
Women were recruited to participate in the study at admission for labour and delivery. Inclusion criteria were: 
gestational age ≥37 + 0 weeks, singleton pregnancies, maternal age ≥18 years. Women with current antibiotic 
use, premature rupture of membranes, preterm delivery, multiple pregnancy, active inflammatory and rheumato-
logic medical conditions, infectious disease, or other chronic condition that could potentially introduce bias were 
excluded from the study. Gestational age at delivery was determined based on the first trimester ultrasound scan. 
All women were offered a routine dating scan at the first prenatal visit to confirm gestational age and to accurately 
determine the estimated date of confinement, as part of the standard of practice.
Study design. Participants were divided into two groups: women who underwent elective caesarean section 
(n = 35) and women who had an emergency caesarean section (n = 44). Maternal blood and amniotic fluid were 
collected from all participants. Samples obtained were coded to maintain confidentiality and to eliminate oper-
ator bias.
Maternal blood was obtained via venipuncture of the cubital vein. Biological samples were collected at admis-
sion, before the CS was performed, and three days postoperatively. Serum samples were collected using EDTA 
blood collection tubes and stored at −80 °C until analysis. The samples had not undergone more than two thaw–
freeze cycles before CRP levels were measured.
Maternal serum hs-CRP levels were determined by enzyme-linked immunosorbent assay (ELISA) using a 
commercially available electrochemiluminescent multiplex assays (Meso Scale Discovery 96-Well Multi-Array 
CRP Assay, Meso Scale Diagnostics, MD, USA). The assay was performed according to manufacturer instruc-
tions. Each sample was examined in duplicate. The method had a sensitivity of 0.33 pg/L and a range of detection 
of 1.33–49 608 pg/mL, being able to measure analytes in very low sample volumes, as it was our case, and without 
multiple dilutions22.
Amniotic fluid specimens were obtained via direct syringe aspiration at the time of the CS and stored at 4 °C 
until analyzed. AF samples were processed for hs-CRP, bacterial count, and culture. AF hs-CRP levels were meas-
ured using the same assay used for analysis of serum samples (Meso Scale Discovery (MSD) 96-Well Multi-Array 
CRP Assay, Meso Scale Diagnostics, MD, USA), following the manufacturer protocol. AF samples were plated 
on several media for bacterial identification. Colombia Blood Agar, and subsequent Gram stain, catalase test, 
Baird-Parker agar base plates, and Rapid Agglutination Test were employed for the identification of bacterial 
species.
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Maternal and neonatal variables. Demographic and clinical variables were abstracted from the clinical 
records for admission to labour and delivery. Information about pregnancy, labour and delivery was linked to 
information on newborn infant using unique identifiers (hospital numbers). The information was collected for 
four categories of variables: (i) maternal variables, which included maternal age, BMI, ethnicity, smoking, use of 
recreational drugs, parity, gestational age at delivery, pregnancy complications, antibiotic use during pregnancy; 
(ii) infant variables included birth weight, colour of liquor, Apgar score at 1 min, gender, cord pH measurements; 
(iii) indication for CS (failure to advance or fetal distress), stage of labor when the CS was performed; and (iv) 
characteristics of labor, including onset of labor, stage of labor, rupture of membranes, number of vaginal exami-
nations, interventions in labor, and use of antibiotics in labor.
Study outcomes. The main outcome of the study was presence of an infectious process associated with CS, 
which was defined as a composite variable of clinical symptoms (pyrexia in labour), diagnosis of postnatal infec-
tion (endometritis, wound infection), bacterial growth, and use of antibiotics in labour. Secondary outcomes were 
neonatal complications including fetal wellbeing at birth, infection, and neonatal unit admission. Apgar score was 
used as a proxy to assess fetal wellbeing at birth.
Statistical analysis. Patient data was anonymized, coded, and entered into an Excel datasheet. Descriptive 
statistics were used to present the demographic and clinical characteristics of the two groups of patients, emer-
gency and elective CS. Categorical variables were compared using the Chi-square test and presented as per-
centage (%). Continuous variables were analysed by one-way analysis of variance ANOVA, or Student t-test, as 
appropriate. The non-normally distributed data of the hs-CRP assays were logarithmically transformed. Pearson’s 
product-moment coefficient was used to measure the dependence between the hs-CRP levels in AF and serum 
in elective and emergency CS, in women with and without bacterial growth. The area under the curve (AUC) 
obtained by the Receiver Operator Curve (ROC) assessed the ability of hs-CRP measurement in AF and Day 0 
and Day 3 serum in predicting CS-associated infection/inflammation in women who had either emergency or 
elective CS.
All reported p-values are 2-sided, and p-values < 0.05 were considered statistically significant. Data were ana-
lyzed using Microsoft Statistical Package for Social Sciences for Windows v23 (SPSS Inc, Chicago, Illinois).
Results
Characteristics of the study population. From the 79 women undergoing CS recruited in the study, 
five were excluded from the final analysis due to inadequate AF samples. The demographic and clinical charac-
teristics of the 74 subjects included in the study are shown in Table 1. The average age of women at the time of 
enrollment was 32.7, ranging from 20 and 42 years old. The majority of women were of Irish descent (87.8%), 
did not smoke during pregnancy (82.4%), had a BMI higher than 25 kg/m2 (61.8%), and delivered after 39 weeks 
gestation (71.7%). The distribution of the gestational age at delivery was as follow: 4 women (5.4%) delivered at 
Characteristics All women (n = 74)a Elective CS (n = 35)
Emergency CS 
(n = 39) p-value
Age (mean ± SD) (range) (years) 32.7 ± 4.8 (20–42) 34.7 ± 4.1 (24–42) 30.9 ± 4.7 (20–41) 0.680
Parity
   Nulliparous 34 (45.9) 6 (17.6) 28 (82.4)
<0.001*
   Multiparous 40 (54.1) 29 (72.5) 11 (27.5)
Nationality n (%)
   Irish 65 (87.8) 31 (89) 34 (87)
0.250
   Non-Irish 9 (12.2) 4 (11) 5 (13)
BMI (kg/m2) n (%)
   18.0–24.9 kg/m2 26 (38.2) 11 (42.3) 15 (57.7)
0.507
   >25.0 kg/m2 42 (61.8) 11 (45.2) 23 (54.8)
Smoking in pregnancy 13 (17.6) 6 (17.1) 7 (17.9) 0.920
Preexisting medical conditions b 29 (39.2) 10 (34.5) 19 (65.5) 0.620
Miscarriage n (%)
   Nil 55 (74.3) 24 (69) 31 (79)
0.120
   One or more 19 (25.7) 11 (31) 8 (21)
Gestational age at delivery (weeks) median (range) 39 (37–42) 39 (37–40) 41 (37–42) 0.001*
Pregnancy complicationsc n (%)
   No 47 (63.5) 24 (68.5) 23 (58.9)
0.390
   Yes 27 (36.5) 11 (31.5) 16 (41.1)
Table 1. Socio-demographic and clinical characteristics of the study population. aMay not add to the total 
number due to missing. bPreexisting medical conditions include: asthma, hypothyroidism, irritable bowel 
syndrome, Chron’s disease, depression, and anxiety. cComplications included: intrauterine growth restriction, 
antepartum haemorrhage, threatened preterm labour, reduced amniotic fluid index, urinary tract infection, 
Group B Spreptococcus positive, Hyperemesis Gravidarum. BMI, Body mass index.
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37 weeks, 17 (23.0%) at 38 weeks, 23 (39.1%) at 39 weeks, 9 (12.2%) at 40 weeks, and 21 (28.4%) women after 
41 weeks gestation. Almost half of women (45.9%) were nulliparous and approximately a third had a history of 
miscarriage (25.7%). Most women were in good health, with no preexisting medical conditions (60.8%), and had 
no pregnancy complications during the index pregnancy (63.5%).
Of the 74 participants, 47% (35/74) of women underwent elective CS and 53% (39/74) emergency CS. As 
expected, the two groups differed by parity and gestational age (p < 0.001 for both) (Table 1). This was likely 
secondary to the fact that most of the elective CS were repeat procedures at 39 weeks gestation. However, the elec-
tive and emergency group did not differ significantly by BMI, nationality, smoking, or pregnancy complications 
(Table 1).
Characteristics of labour, delivery, and postpartum infectious morbidity in the two groups, elective and emer-
gency CS, are presented in Table 2. The primary indication for elective CS was repeat elective CS (83%), whereas 
presumed fetal compromise with non-reassuring CTG was the most frequent indication for emergency CS (54%). 
Women who underwent emergency CS were more likely to have had their labour induced (71.8%) (p < 0.001). 
Among induction methods, 46.2% of women who delivered by emergency CS were administrated PGE2. Ninety 
seven percent of women who had an elective CS had intact membranes, whereas in the emergency CS group, 92% 
had membranes ruptured either spontaneously or artificially. Six women in the emergency CS group developed 
pyrexia in labour and ten received antibiotics. Infectious morbidity in postpartum was present in 17% of women 
who had elective CS and 8% of women who underwent emergency CS.
Secondary neonatal outcomes are presented in Table 2. More than 97% (70/74) of babies had an Apgar score 
higher than 7 at one minute, and all babies had Apgar score higher than 7 at 5 minutes. Eight percent of new-
borns were admitted to neonatal intensive unit (6/74) for congenital pneumonia (n = 1), transient tachypnea of 
newborn (n = 3), or for other causes (n = 2). Two newborns had a birth weight less than 2500 g, and 15 babies 
were macrosomic, weighting more than 4000 g, with the rest being adequate for gestational age (birthweight 
2500–4000 g). The gender distribution was equivalent (50% female and 50% males) (Table 2).
Feasibility of AF sample collection. In 6% of cases (5/79), AF could not be analyzed after CS, as it was 
either of insufficient amount or could not be processed due to thick meconium. Adequate AF sample were 
obtained from all the elective CS. In the emergency CS group, 26% of samples (10/39) were obtained through 
intact amnion, while the rest of samples were obtained after amnion incision or rupture. In 7% of the emergency 
cases (3/44) there was little amniotic fluid left around the baby. In 5% of emergency cases (2/44) the operator 
was able to aspirate thick meconium; however, due to its consistency, preparation of the sample for the hs-CRP 
assay measurement (separation by centrifugation) was not possible. In the elective group, 86% of amniotic fluid 
samples (30/35) were obtained by direct needle aspiration through intact amnion. The remaining 14% (5/35) of 
samples were obtained after unintended spontaneous rupture of the amnion.
Bacterial growth in AF samples. Bacterial count was performed for all 74 women from whom an amni-
otic fluid sample was obtained. Almost 60% (44/74) of AF samples collected showed bacterial colonization: 46% 
of elective CS (16/35) and 72% of emergency CS cases (28/39). Among the AF samples with positive bacterial 
growth, 43% (19/44) had subsequent bacterial typing performed. Every bacterial isolate was Gram stained and 
catalase tested. Further testing included antibiotic disc sensitivity testing, MRSA, and Baird-Parker selection agar 
testing and agglutination tests. From these presumptive tests, five isolates were selected for confirmatory StaphAPi 
analysis, as all presumptive tests had indicated towards Staphylococcus. Three showed Staphylococcus epidermidis 
and the other two showed Staphylococcus lugdunensis. That was an interesting discovery as Staphylococcus lug-
dunensis, a virulent coagulase-negative staphylococcus, has not been previously isolated from amniotic fluid22. 
Bacterial growth was almost 3 times more likely to occur in emergency CS as compared to elective CS (OR 3.0, 
95% CI 1.2–7.9).
hs-CRP levels in AF and serum of women undergoing CS. hs-CRP was measured in AF samples col-
lected from 74 women, 35 who underwent elective and 39 who had emergency CS (100% of sample). All 35 
women in the elective group and 38 of women in the emergency group (97%, 38/39) had a pre-operative blood 
sample collected for measurement of hs-CRP (Day 0 hs-CRP). More than 90% of women provided a blood sam-
ple in the day 3 postoperatively for measurement of hs-CRP (Day 3 hs-CRP), 33 women in the elective group 
(94%, 33/35) and 35 women in the emergency CS group (90%, 35/39). Blood samples were not collected from six 
women, who were discharged earlier than day 3 postoperatively from the hospital.
Mean AF hs-CRP levels were approximately 10 times higher among the women undergoing emergency CS 
(1,333 ng/ml) compared with women who had an elective CS (134 ng/ml; p = 0.009) (Table 3).
hs-CRP levels were higher in the serum collected in Day 0 in women who underwent emergency CS than in 
women who had planned CS (p < 0.001) However, at day three (Day 3 serum) the levels of hs-CRP did not vary 
significantly between the elective (mean 97,805 ng/ml) and emergency group (mean 75,892 ng/ml) (p = 0.959) 
(Table 3).
Correlation between clinical and demographic characteristics and hs-CRP levels in women who 
underwent emergency or elective CS. Among women with bacterial growth in the AF samples, levels 
of hs-CRP were higher in the AF (p = 0.041) and Day 0 serum (p = 0.020) but not in Day 3 serum (p = 0.070) in 
women who underwent emergency CS compared to women who had an elective CS.
Among women who developed postpartum infection, hs-CRP was higher in Day 3 serum in women who 
underwent elective CS than in women with emergency CS (p = 0.021), whereas there was no difference in hs-CRP 
levels in Day 0 serum or AF.
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Characteristic
Elective CS 
(n=35)
Emergency CS 
(n=39)
Indication for CS n (%)
 Elective CS
    Repeat CS 29 (83) —
    Breech presentation 3 (9) —
    Other indication 3 (9) —
 Emergency CS
    NRCTG — 21 (54)
    FTP — 9 (23)
    Failed IOL — 7 (18)
    Malpresentation — 1 (3)
    Other — 1 (3)
Cervical dilation n (%)
    1–3 cm — 20 (53)
    4–6 cm — 8 (21)
    7–9 cm — 6 (16)
    10 cm — 4 (11)
Antibiotics at CS n (%)
    Given 34 (97) 39 (100)
    Not given 1 (1) —
Onset of labor n (%)
    Not in labor 34 (97.1) 1(2.7)
    SOL 1 (2.9) 9 (23.1)
    IOL — 28 (71.8)
Mode of labour induction n (%)
    PGE2 — 18 (46.2)
    ARM — 2 (5.1)
    Syntocinon — 2 (5.1)
    No induction — 17 (43.6)
Length of the 1st stage1 (h) — 14.00 (4–45)
Length of the 2st stage1 (h) — 1.00 (1–2)
Membranes at the time of CS n (%)
    Intact 34 (97.1) 3 (8)
    SROM 1 (2.9) 14 (36)
    ARM — 22 (56)
    Interval ROM to delivery1 (h) 2h only in 1 case 10.30 (1–59)
Number of VE
    Before ROM1 — 3.00 (0–7)
    After ROM1 — 6.00 (0–13)
Number of FBS in labor n(%)
    Nil — 26 (67)
    1 — 10 (27)
    2 — 2 (5)
    3 — 1 (3)
Pyrexia in labor n (%)
    Absent — 33 (85)
    Present — 6 (15)
Antibiotics in labor n (%)
    No — 29 (74)
    Yes — 10 (26)
Cord pH n (%)
 Not performed — 26 (67)
 Arterial
    >7.25 — 3 (8)
    7.20–7.25 — 4 (10)
    <7.20 — 5 (13)
Continued
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There was a significant difference in hs-CRP levels in AF and Day 3 serum samples of women with a 
BMI > 25 kg/m2, hs-CRP being higher in AF and lower in Day 0 serum of women with increased BMI (over-
weight and obese) who underwent emergency CS (p = 0.007 and p = 0.003, respectively) compared to women 
who had an elective CS. Women who smoked during pregnancy from the elective CS group had significantly 
higher Day 0 serum hs-CRP levels than women from emergency CS group (p = 0.038). There was no difference 
in the hs-CRP levels in the serum or AF of smokers who underwent emergency CS or in Day 3 serum and AF of 
smokers who had an elective CS.
In the emergency CS group, the levels of hs-CRP were higher in Day 0 serum in women who had at least one 
vaginal examination in labour (p < 0.001) as compared to women who had no examination, and Day 3 serum 
in women who had pyrexia in labour (p = 0.003) as compared to women who had normal body temperature. 
No other clinical and demographic risk factors (parity, number of miscarriages, preexistent medical conditions, 
nationality, antibiotics administered in labour, fetal blood sampling, or membrane rupture) in the emergency CS 
group had a significant influence on serum or AF hs-CRP levels.
Parity influenced the levels of hs-CRP in elective CS group. In this group, multiparous women had higher 
levels of hs-CRP in Day 3 serum than nulliparous women (p < 0.001).
A Pearson correlation was run to determine the relationship between the levels of hs-CRP in AF and serum 
in women who underwent CS. Overall, there was a moderate, positive correlation between hs-CRP levels in AF 
and Day 0 serum (r = 0.453, p < 0.001) and a weak correlation between hs-CRP levels in AF with Day 3 serum 
(r = 0.270, p = 0.031). When stratified by the type of CS, in women who underwent emergency CS, a positive 
correlation was noted between hs-CRP levels in AF with Day 0 serum (r = 0.443, p = 0.006), but not with Day 
3 serum (r = 0.267, p = 0.127). Statistically significant correlations were observed between hs-CRP from Day 0 
serum with hs-CRP levels in the AF (r = 0.754, p < 0.001) and with Day 3 levels of hs-CRP in serum (r = 0.467, 
p = 0.007) in women who underwent elective CS. The odds of evidence of an inflammatory process were 3.6 times 
higher in emergency CS than in elective CS (OR 3.6, 95% CI 1.3–10.1) (Supplemental Figure 1).
Characteristic
Elective CS 
(n=35)
Emergency CS 
(n=39)
 Venous
    >7.25 — 9 (23)
    7.20–7.25 — 1 (3)
    <7.20 — 3 (8)
Postpartum infection n (%)
 Absent 29 (83) 36 (92)
 Present 6 (17) 3 (8)
    Wound infection 2 (6) 3 (8)
    Endometritis 3 (9) —
    Pyrexia 1 (3) —
Newborn Outcomes
   Apgar score 1 min >7 34 (100.0) 36 (94.7)
   Apgar score 5 min >7 34 (100.0) 38 (100.0)
   Neonatal unit admission 2 (5.7) 4 (10.3)
   Birth weight
    <2,500g 1 (1.4) 1 (1.4)
    2500–4000g 29 (39.2) 28 (37.8)
    >4000g 5 (6.8) 10 (13.5)
   Gender
    Female 16 (21.6) 21 (28.4)
    Male 19 (25.7) 18 (24.3)
Table 2. Characteristics of labor, delivery, and postpartum infectious morbidity. Abbreviations: NRCTG, non-
reassuring CTG; FTP, failure to progress; IOL, induction of labour; SOL, spontaneous onset of labour; PGE2, 
prostaglandin E2; ARM, artificial rupture of membranes; SROM, spontaneous rupture of membranes; ROM, 
rupture of membranes; FBS, fetal blood sampling. 1Data presented as median (range). Note: The length of the 1st 
stage includes latent, active, and transitional phase.
hs-CRP levels (103 ng/ml) Elective CS n = 35 Emergency CS n = 39 p-value
Amniotic fluid 0.134 (0.050–0.218) 1.333 (0.394–2.272) 0.004*
Day 0 serum 7.965 (4.009–11.923) 134.6 (95.868–365.165) <0.001*
Day 3 serum 97.805 (72.884–122.726) 75.892 (54.636–97.147) 0.959
Table 3. hs-CRP levels in AF and maternal serum measured at elective and emergency CS. Data are 
presented as mean (95% CI). Student t-test applied to compare between elective and emergency CS hs-CRP in 
logarithmically transformed data.
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The area under the curve (AUC) obtained by the Receiver Operator Curve (ROC) assessed the ability of 
hs-CRP measurement in AF and serum in predicting inflammatory/infectious process in women who underwent 
either emergency or elective CS (Table 4). Whereas AUC was significant for hs-CRP measurement in Day 0 and 
Day 3 serum in emergency CS, indicating good value of hs-CRP in predicting inflammatory processes in these 
cases, the AUC showed low predicting value of the inflammatory marker in AF or serum in women who under-
went elective CS (Table 4).
Discussion
This study evaluated the propensity of AF hs-CRP in predicting CS-associated infection and inflammation. By 
using ROC plot analysis, our findings suggest that AF hs-CRP does not predict inflammation in women who 
deliver by CS, whereas serum hs-CRP appears to be a better predictor of inflammation/infection in emergency 
than in elective CS. Considering low predictor value of infection and technical difficulties in harvesting and ade-
quate sampling, AF hs-CRP does not appear a feasible marker to assess the risk of an infectious process in women 
who deliver by CS. However, hs-CRP may have value in identifying low levels of inflammation that may progress 
towards sepsis in labour or postnatal infection.
The choice of measuring hs-CRP in our samples was two-fold. Firstly, evidence shows that particular proteins 
such as CRP or other molecules could provide a “signature” for detection of “sublinical” amniotic fluid inflam-
mation that may be predictive and could pick up infection at an early stage23,24. Secondly, we were interested to 
detect low levels of inflammation in small biologic samples. The commercially available hs-CRP assays use low 
amounts of sample (microliters). Nonetheless, previous studies have shown that, despite difference in the levels of 
detection, there is a strong, significant correlation between the levels of wide-range measured through standard 
immunoturbidometric assay (i.e. COBAS® Integra, Siemens Advia systems) and high-sensitivity CRP in biologic 
samples25,26. Furthermore, we were aware of potential sampling issues that could arise at the harvesting of AF, 
especially in women with ruptured membranes.
This study has shown the ability of measuring hs-CRP in less than 1 mL of AF in both elective and emer-
gency CS deliveries. However, even though less than 1 mL of fluid was required for hs-CRP analysis, in three 
emergency cases no amniotic fluid was obtained. Also, the consistency of the amniotic fluid sample influenced 
the chance of success. In two of the emergency CS cases thick meconium aspirated with a plain syringe proved 
the sample preparation inadequate for the hs-CRP assay, although bacterial colonization could still be analyzed. 
Consequently, we conclude that analysis of AF hs-CRP can be limited at the CS by both, insufficient amount or 
inadequate consistency of AF samples.
Contamination of the amniotic fluid samples with maternal blood and cells may have posed pre-analytical 
bias to our study and should also be taken into consideration, particularly for the cases of pre-ruptured amnion27. 
Although for most of the samples in elective CS group the AF samples were harvested through the intact amnion, 
the pre-contamination with maternal cells was still possible. Thus, it is possible that the levels of hs-CRP may not 
truly reflect the levels of this inflammatory marker in the AF. Routinely harvesting AF samples in emergency CS 
may not be always feasible. The operator may be reluctant to do so when trying to deliver a presumed compro-
mised fetus without delay28. Furthermore, the risk of fetal skin damage by puncture associated with the use of 
needle aspiration described in other studies needs to be appreciated, although these risks did not materialize in 
our study.
Despite measures to decrease the incidence of postoperative infection, such as changes in operative tech-
niques and prophylactic antibiotics before skin incision1, the rate of infectious morbidity after CS remains high. 
Therefore, finding a new method or marker that could predict the risk of sepsis and postoperative infection would 
be extremely useful. In our study, AF hs-CRP levels were significantly higher in emergency compared to elective 
CS cases, but whether this can be used clinically and to what benefit is still uncertain. It is conceivable that AF 
hs-CRP measurement might be of more relevance in those emergency cases that occur at the end of a prolonged 
labor, where the risk of post-partum infectious morbidity is much higher.
The higher levels of Day 0 serum hs-CRP as compared to Day 3 in women who delivered by emergency 
C-section may reflect increase in the inflammatory marker following rupture of membranes and physiological 
changes in response to elevated serum concentrations of estrogen, progestogen and prostaglandins20,29 or to the 
tissue injury consecutive the procees of labour itself29. The rise in Day 0 CRP levels might have been medi-
ated, at least in part, by the stress response associated to surgical trauma and additional potentiating effects of 
anesthesia30.
In contrast, Day 3 serum hs-CRP levels were significantly elevated in the elective CS group in comparison 
to the pre-operative level. For these cases it is likely that the higher postoperative levels may be a consequence, 
at least in part, to tissue trauma associated with the operation. Similar with our study, a previous report from 
Keski-Nisula et al. showed a significant peak of serum CRP on day 2 In parturients operated upon after the onset 
All cases Emergency CS Elective CS
AUC 95% CI AUC 95% CI AUC 95% CI
hs-CRP in AF 0.590 0.457–0.722 0.558 0.331–0.784 0.518 0.316–0.721
hs-CRP in Day 0 serum 0.648 0.522–0.773* 0.767 0.606–0.928* 0.503 0.305–0.701
hs-CRP in Day 3 serum 0.605 0.460–0.749 0.791 0.645–0.036* 0.602 0.401–0.803
Table 4. Performance of hs-CRP in AF and serum for prediction of an inflammatory/infection process in 
women who undergo CS. *p < 0.05.
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of labor or ruptured membranes18,31. The postoperative values remaining elevated up to the sixth postoperative 
day than in parturients operated upon with intact membranes or not in labor31. Several systematic reveiwes and 
meta-analyses assessed recently the predictive value of CRP in major abdominal surgery, showing that day 3 post-
operative CRP levels are predictive of infectious complications and may aid patient selection for safe and early 
hospital discharge, guide the need for additional investigations, or prevent overuse of imaging32,33.
Intra-amniotic inflammation is a risk factor for adverse pregnancy and neonatal outcome, regardless of the 
presence or absence of a positive amniotic fluid culture34. It has been shown that bacteria have the ability to cross 
through intact membranes35 and asymptomatic microbial colonization has been reported as a cause of preterm 
premature rupture of membranes and pre-term labor. This could explain the positive amniotic fluid cultures in 
46% of women in our elective group; the number could be much higher since up to 99% or more of microbial 
species visualized by microscopy are uncultivable36. This would strengthen the potential role of AF hs-CRP in 
diagnosing subclinical or an early infectious process that has already started in utero. Since hs-CRP does not 
cross the placenta values obtained from the AF represent fetal source as a reaction to external or internal stimuli37.
The main limitation of our study is the relatively small sample size. However, our primary aim was to exam-
ine the feasibility of measurement of hs-CRP in AF and not to definitely prove its association with post-partum 
infectious morbidity. Furthermore, we did not include in our analyses the duration of labour prior to surgery, 
with or without ruptured membranes, the duration of the operation itself, or the duration of internal monitoring 
before operation.
We appreciate that information on endometrial, placental, and membrane histology to determine whether 
inflammatory reactions were present in cases with raised hs-CRP would have been instrumental in differentia-
tion between inflammation and infection. Placental cultures, should they have been available to this study, would 
validate the AF culture findings.
We acknowledge that several new biomarkers of inflammation have been recently studied. Among many of 
the inflammatory markers potentially available, very few were found of value for routine clinical practice. For 
instance, procalcitonin, is a recently discovered, promising biomarker of inflammation. Its value has been tested 
in blood and seems to be more significant for sever sepsis/septic shock38. Although procalcitonin has proved to 
be a potential marker for sepsis, its physiological role remains still uncertain39. In addition, the normal values 
of procalcitonin in pregnancy have not been defined and validated and there is little information on its value in 
pregnancy40. Furthermore, although procalcitonin has been examined previously in blood and amniotic fluid, 
those studies have not been translated into clinical practice41. Thus, our preference to hs-CRP reside in the fact 
that this is a commoly used marker of inflammation in routine clinical practice, with values and clinical signifi-
cance most clinicians are familiar. 
Erythorcyte sedimentation rate (ESR) is routinely used as a common marker of inflammation in clinical prac-
tice. We did not included ESR in our study for several reasons. Firstly, there is evidence in the literature of the 
association between CRP and not ESR with inflammation in pregnant and non-pregnant patients. CRP values 
des not vary with gestational age or other pregnancy complications. Secondly, ESR indirectly measures inflam-
mation in the blood by assessing the rate at which red blood cells sediment in a period of one hour. Thirdly, ESR 
is a non-specific test, not reliable as a measure of inflammation in pregnancy. ESR is increased in several circum-
stances beside infection/inflammation including anaemia, malignant disease, aging, and pregnancy42. Previous 
studies have shown that, in pregnancy, ESR levels are dependent on gestational age, anaemia, low albumin, other 
pregnancy complications43. Caesarean section in itself may influence the value of ESR. Furthermore, by its defi-
nition, ESR is a blood test, which would preclude its use as a desired test of amniotic fluid. In addition, we did not 
add this test to our methodology to avoid bias due to high frequency of these two tests in providing discordant 
results44.
In conclusion, prediction of postpartum and post-operative infectious complications remains a great chal-
lenge after caesarean section. This study has proven the ability of measuring hs-CRP in less than 1 ml of AF in 
both elective and emergency CS settings. In our study, AF hs-CRP levels were significantly higher in emergency 
compared to elective CS, but whether or not this test can be used in a clinical setting warrants further investiga-
tion in larger studies. The wide range of serum CRP concentrations during the puerperium precludes, however, 
its use as a simple serum marker of obstetric postoperative complications.
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